tm logo

Monitor this mark

View On USPTO

ZUNISLA
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 09 Dec 2024

Last Applicant/ Owned by

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston

MA

02210

Serial Number

98080582 filed on 11th Jul 2023

Registration Number

N/A

Correspondent Address

Sarah Anne Keefe

Sarah Anne Keefe WOMBLE BOND DICKINSON (US) LLP

BOSTON, MA 02210

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ZUNISLA

Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for treating diabetes; medical treatments in the nature of anti-diabetic pharmaceuticals; stem cell-derived cell therapy composed of cells for medical or veterinary use

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 98080582

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
09th Dec 2024SOU EXTENSION 1 GRANTED
09th Dec 2024SOU EXTENSION 1 FILED
09th Dec 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09th Dec 2024SOU TEAS EXTENSION RECEIVED
02th Jul 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07th May 2024PUBLISHED FOR OPPOSITION
07th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04th Apr 2024EXAMINER'S AMENDMENT ENTERED
04th Apr 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED